Literature DB >> 17485972

Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years.

Arne H Strand1, Helga Gudmundsdottir, Eigil Fossum, Ingrid Os, Reidar Bjørnerheim, Sverre E Kjeldsen.   

Abstract

Left ventricular (LV) hypertrophy is related to blood pressure level and neurohormonal factors. The authors previously demonstrated that arterial norepinephrine levels predict LV mass in middle-aged men who developed hypertension through 20 years. The aim of this 20-year prospective study was to investigate arterial vasopressin, aldosterone, and renin as long-term predictors of LV mass. Normotensives (n=17), subjects who developed hypertension (n=17), and sustained hypertensives (n=22) were compared at baseline (42 years) and at follow-up (62 years). There were no significant differences in baseline vasopressin, aldosterone, or renin levels. The group with sustained hypertension had more LV hypertrophy (P=.025) at follow-up. Among new hypertensives, multiple regression analysis demonstrated that baseline arterial vasopressin (beta-0.53; P=.041) and aldosterone (beta-0.56;P=.032) independently explained LV mass index (R(2)=0.85; P=.035). In conclusion, baseline arterial vasopressin and aldosterone, but not renin, appear to predict LV mass in middle-aged men who developed hypertension over a 20-year period.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485972      PMCID: PMC8109877          DOI: 10.1111/j.1524-6175.2007.06479.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

Review 1.  Hypertension, hypertrophy, hormones, and the heart.

Authors:  S P Glasser
Journal:  Am Heart J       Date:  1998-02       Impact factor: 4.749

2.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

Review 3.  Neurohormonal activation in congestive heart failure and the role of vasopressin.

Authors:  Kanu Chatterjee
Journal:  Am J Cardiol       Date:  2005-05-02       Impact factor: 2.778

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Decreased central dopaminergic activity in essential hypertension.

Authors:  I Os; S E Kjeldsen; A Westheim; I Aakesson; N Norman; E Enger; I Hjermann; I Eide
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

Review 6.  Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.

Authors:  Tera D Moore; James J Nawarskas; Joe R Anderson
Journal:  Heart Dis       Date:  2003 Sep-Oct

7.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Authors:  A W Haider; M G Larson; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

8.  Heart rate as marker of sympathetic activity.

Authors:  G Grassi; S Vailati; G Bertinieri; G Seravalle; M L Stella; R Dell'Oro; G Mancia
Journal:  J Hypertens       Date:  1998-11       Impact factor: 4.844

9.  Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.

Authors:  C G Brilla; L S Matsubara; K T Weber
Journal:  J Mol Cell Cardiol       Date:  1993-05       Impact factor: 5.000

10.  Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor.

Authors:  Xue-Dong Yang; Lian-You Zhao; Qiang-Sun Zheng; Xue Li
Journal:  J Cardiovasc Pharmacol       Date:  2003-07       Impact factor: 3.105

View more
  3 in total

Review 1.  Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.

Authors:  Gino Seravalle; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-05-01

2.  Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients.

Authors:  Ping Wen; Dan Song; Hong Ye; Xiaochun Wu; Lei Jiang; Bing Tang; Yang Zhou; Li Fang; Hongdi Cao; Weichun He; Yafang Yang; Chunsun Dai; Junwei Yang
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

3.  Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.

Authors:  Julio A Chirinos; Mayank Sardana; Garrett Oldland; Bilal Ansari; Jonathan Lee; Anila Hussain; Anique Mustafa; Scott R Akers; Wen Wei; Edward G Lakatta; Olga V Fedorova
Journal:  ESC Heart Fail       Date:  2018-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.